We are live on
!
Find out more
Corbus Pharmaceuticals
CRBP
CRBP
81 hedge funds and large institutions have $109M invested in Corbus Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 17 increasing their positions, 24 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
2.25% less ownership
Funds ownership: 74.06% → 71.81% (-2.2%)
29% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 24
Holders
81
Holding in Top 10
–
Calls
$6.38M
Puts
$1.69M
Top Buyers
| 1 | +$1.1M | |
| 2 | +$812K | |
| 3 | +$786K | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$662K |
| 5 |
SCM
Superstring Capital Management
New York
|
+$548K |
Top Sellers
| 1 | -$2.25M | |
| 2 | -$1.19M | |
| 3 | -$651K | |
| 4 |
Charles Schwab
San Francisco,
California
|
-$470K |
| 5 |
EAM
Exome Asset Management
New York
|
-$450K |